COVID-19 Response: Local Logistics     National Effort       

Tailor-made ezrin actin binding domain to probe its interaction with actin in-vitro. [Protein Technology Core]

You are here

COVID-19 Response: Local Logistics     National Effort

TitleTailor-made ezrin actin binding domain to probe its interaction with actin in-vitro. [Protein Technology Core]
Publication TypeJournal Article
Year of Publication2015
AuthorsShrivastava R, Köster D, Kalme S, Mayor S, Neerathilingam M
JournalPLoS One
Volume10
Issue4
Paginatione0123428
Date Published2015
ISSN1932-6203
KeywordsActins, Animals, Avian Proteins, Chickens, Cytoskeletal Proteins, In Vitro Techniques, Microfilament Proteins, Models, Molecular, Protein Interaction Domains and Motifs, Recombinant Fusion Proteins
Abstract

Ezrin, a member of the ERM (Ezrin/Radixin/Moesin) protein family, is an Actin-plasma membrane linker protein mediating cellular integrity and function. In-vivo study of such interactions is a complex task due to the presence of a large number of endogenous binding partners for both Ezrin and Actin. Further, C-terminal actin binding capacity of the full length Ezrin is naturally shielded by its N-terminal, and only rendered active in the presence of Phosphatidylinositol bisphosphate (PIP2) or phosphorylation at the C-terminal threonine. Here, we demonstrate a strategy for the design, expression and purification of constructs, combining the Ezrin C-terminal actin binding domain, with functional elements such as fusion tags and fluorescence tags to facilitate purification and fluorescence microscopy based studies. For the first time, internal His tag was employed for purification of Ezrin actin binding domain based on in-silico modeling. The functionality (Ezrin-actin interaction) of these constructs was successfully demonstrated by using Total Internal Reflection Fluorescence Microscopy. This design can be extended to other members of the ERM family as well.

DOI10.1371/journal.pone.0123428
Alternate JournalPLoS ONE
PubMed ID25860910
PubMed Central IDPMC4393143